Literature DB >> 19797229

Aliphatic beta-nitroalcohols for therapeutic corneoscleral cross-linking: chemical mechanisms and higher order nitroalcohols.

David C Paik1, Marissa R Solomon, Quan Wen, Nicholas J Turro, Stephen L Trokel.   

Abstract

PURPOSE: The recent tissue cross-linking studies indicate that aliphatic beta-nitroalcohols (BNAs) may be useful as pharmacologic corneoscleral cross-linking agents. The present study was performed to identify the specific chemistry involved under physiologic conditions, with the intent of identifying more effective agents.
METHODS: The mechanism of chemical cross-linking at pH 7.4 and 37 degrees C was studied using three techniques. The colorimetric Griess assay was used to follow the release of nitrite from three mono-nitroalcohols (2-nitroethanol [2ne], 2-nitro-1-propanol [2nprop]), and 3-nitro-2-pentanol [3n2pent]). Second, the evolution of 2nprop in 0.2 M NaH(2)PO(4)/Na(2)HPO(4)/D(2)O was studied using (1)H-NMR. Third, thermal shrinkage temperature analysis (T(s)), a measure of tissue cross-linking, was used to support information from (1)the H-NMR studies.
RESULTS: A time-dependent release of nitrite was observed for all three mono-nitroalcohols studied. The maximum levels were comparable using either 2ne or 2nprop (approximately 30%). However, much less (approximately 10%) was observed from 3n2pent. Using (1)H-NMR, 2nprop evolved into a unique splitting pattern. No match was observed with reference spectra from three possible products of denitration. In contrast, 2-methyl-2-nitro-1,3-propanediol (MNPD), a nitro-diol, was identified, implying the formation of formaldehyde from a retro-nitroaldol (i.e., reverse Henry) reaction. In support of this mechanism, T(s) shifts induced by the nitro-triol 2-hydroxymethyl-2-nitro-1,3-propanediol (HNPD) were superior to the nitro-diol MNPD which were superior to the mono nitroalcohol 2nprop.
CONCLUSIONS: BNAs function as both formaldehyde and nitrite donors under physiologic conditions to cross-link collagenous tissue. Higher order BNAs are more effective than mono nitroalcohols, raising the possibility of using these agents for therapeutic corneoscleral cross-linking.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19797229      PMCID: PMC2868449          DOI: 10.1167/iovs.09-3937

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  10 in total

1.  Nitrite-induced cross-linking alters remodeling and mechanical properties of collagenous engineered tissues.

Authors:  David C Paik; Lynne Y Saito; Dorcas D Sugirtharaj; Jeffrey W Holmes
Journal:  Connect Tissue Res       Date:  2006       Impact factor: 3.417

Review 2.  Safety of UVA-riboflavin cross-linking of the cornea.

Authors:  Eberhard Spoerl; Michael Mrochen; David Sliney; Stephen Trokel; Theo Seiler
Journal:  Cornea       Date:  2007-05       Impact factor: 2.651

Review 3.  Formaldehyde toxicity--new understanding.

Authors:  H D Heck; M Casanova; T B Starr
Journal:  Crit Rev Toxicol       Date:  1990       Impact factor: 5.635

4.  Biomechanical evidence of the distribution of cross-links in corneas treated with riboflavin and ultraviolet A light.

Authors:  Markus Kohlhaas; Eberhard Spoerl; Thomas Schilde; Gabriele Unger; Christine Wittig; Lutz E Pillunat
Journal:  J Cataract Refract Surg       Date:  2006-02       Impact factor: 3.351

5.  Evaluation of secondary nitroalkanes, their nitronates, primary nitroalkanes, nitrocarbinols, and other aliphatic nitro compounds in the Ames Salmonella assay.

Authors:  C C Conaway; N S Hussain; B M Way; E S Fiala
Journal:  Mutat Res       Date:  1991-11       Impact factor: 2.433

Review 6.  Crosslinking treatment of progressive keratoconus: new hope.

Authors:  Gregor Wollensak
Journal:  Curr Opin Ophthalmol       Date:  2006-08       Impact factor: 3.761

7.  Vicinal nitrohydroxyeicosatrienoic acids: vasodilator lipids formed by reaction of nitrogen dioxide with arachidonic acid.

Authors:  M Balazy; T Iesaki; J L Park; H Jiang; P M Kaminski; M S Wolin
Journal:  J Pharmacol Exp Ther       Date:  2001-11       Impact factor: 4.030

8.  Experimental use of 2-nitropropanol for reduction of Salmonella Typhimurium in the ceca of broiler chicks.

Authors:  Yong Soo Jung; Robin C Anderson; Thomas S Edrington; Kenneth J Genovese; J Allen Byrd; Todd R Callaway; David J Nisbet
Journal:  J Food Prot       Date:  2004-09       Impact factor: 2.077

9.  Aliphatic beta-nitro alcohols for non-enzymatic collagen cross-linking of scleral tissue.

Authors:  David C Paik; Quan Wen; Suzanna Airiani; Richard E Braunstein; Stephen L Trokel
Journal:  Exp Eye Res       Date:  2008-06-19       Impact factor: 3.467

10.  Initial studies using aliphatic beta-nitro alcohols for therapeutic corneal cross-linking.

Authors:  David C Paik; Quan Wen; Richard E Braunstein; Suzanna Airiani; Stephen L Trokel
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-10-03       Impact factor: 4.799

  10 in total
  7 in total

1.  Using the Griess colorimetric nitrite assay for measuring aliphatic β-nitroalcohols.

Authors:  Quan Wen; David C Paik
Journal:  Exp Eye Res       Date:  2012-03-03       Impact factor: 3.467

2.  Aliphatic β-nitroalcohols for therapeutic corneoscleral cross-linking: chemical stability studies using 1H-NMR spectroscopy.

Authors:  Xia Li; Yongjun Li; Mijung Kim; Stephen L Trokel; Nicholas J Turro; David C Paik
Journal:  Photochem Photobiol       Date:  2013-10-21       Impact factor: 3.421

3.  Pharmacologic alternatives to riboflavin photochemical corneal cross-linking: a comparison study of cell toxicity thresholds.

Authors:  MiJung Kim; Anna Takaoka; Quan V Hoang; Stephen L Trokel; David C Paik
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-04-10       Impact factor: 4.799

4.  Mechanistic and Catalytic Studies of β-Nitroalcohol Crosslinking with Polyamine.

Authors:  Xia Li; Yongjun Li; Yi Rao; Marissa R Solomon; David C Paik; Nicholas J Turro
Journal:  J Appl Polym Sci       Date:  2013-06-15       Impact factor: 3.125

5.  Aliphatic β-nitroalcohols for therapeutic corneoscleral cross-linking: corneal permeability considerations.

Authors:  Quan Wen; Stephen L Trokel; MiJung Kim; David C Paik
Journal:  Cornea       Date:  2013-02       Impact factor: 2.651

Review 6.  Potential Effects of Corneal Cross-Linking upon the Limbus.

Authors:  Johnny E Moore; Davide Schiroli; C B Tara Moore
Journal:  Biomed Res Int       Date:  2016-09-05       Impact factor: 3.411

7.  Antimicrobial Studies Using the Therapeutic Tissue Cross-Linking Agent, Sodium Hydroxymethylglycinate: Implication for Treating Infectious Keratitis.

Authors:  Patrick B Rapuano; Alexandra H Scanameo; Daeryl E Amponin; Sefy A Paulose; Mariya Zyablitskaya; Anna Takaoka; Leejee H Suh; Takayuki Nagasaki; Stephen L Trokel; David C Paik
Journal:  Invest Ophthalmol Vis Sci       Date:  2018-01-01       Impact factor: 4.799

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.